73 JEDDAH: A Saudi medical team has successfully used modern immunosuppressive therapy for a five year old Saudi girl with Glioblastoma, a grade 4 brain tumor known for being aggressive and very infiltrative. The medical team from the King Fahd Medical City used the modern therapy after traditional methods such as surgery, radiotherapy, and chemotherapy failed to treat her case. The new technology, according to the Saudi Press Agency, has successfully treated the girl without experiencing immunotherapy complications. Dr. Musa Alharbi, Director of the Comprehensive Cancer Center a King Fahd Medical City, said the Saudi girl’s case was “very rare and the first of its kind in the Arab world.” The girl suffers from constitutional mismatch repair deficiency syndrome, a hereditary cancer predisposition that typically presents in infancy, childhood or young adulthood. Alharbi ensured that the girl’s situation was now stable. He added that this study opens the prospects of clinical trials and encourages pursuing further cases of genetic tumors in the medical city to serve patients and their families. The medical city will work in cooperation with the Department of Genomic Research, he said, which aims to develop a national program to examine genetic tumors to undergo early intervention in treatment, which will be the first of its kind in the region. He noted that this study has been accepted by The Oncologist, a peer-reviewed monthly cancer medicine journal. It has also earned the recognition of several reviewers in international conferences in the United States.